IVZ vs KYMR · rev $3.57B vs rev $99.4M
Invesco Plc (IVZ) versus Kymera Therapeutics Inc (KYMR) — a side-by-side from cached financials, not a winner call.
Invesco Plc (IVZ) is a asset management company listed on NYSE.
Kymera Therapeutics Inc (KYMR) is a biotechnology company listed on NASDAQ.
Latest reported IVZ revenue for 2026-06-30 was $3.57B. Net income was $558.0M. IVZ currently screens at market cap $12.76B.
Latest reported KYMR revenue for 2026-06-30 was $99.4M. Net income was -$130.4M. KYMR currently screens at market cap $7.39B.
IVZ currently screens at market cap $12.76B. KYMR currently screens at market cap $7.39B.
Not investment advice. Open the IVZ and KYMR stock pages for the full models.
Not investment advice.